First Frameshift Mutation of ALK in Non-Small Cell Lung Cancer Remaining Sensitive to Alectinib: Case Report

Xiaoqian Zhai1, Zuoyu Liang2, Cheng Zhen3

  • 1Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Clinical Lung Cancer
|February 24, 2026
PubMed
Summary

No abstract available in PubMed .